475 related articles for article (PubMed ID: 7594922)
41. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen.
Jamet P; Ji B
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):622. PubMed ID: 7868967
[No Abstract] [Full Text] [Related]
42. A case of lepromatous leprosy with multiple relapses.
Hulmani M; Marne RB; Dandakeri S
Lepr Rev; 2009 Jun; 80(2):210-4. PubMed ID: 19743626
[TBL] [Abstract][Full Text] [Related]
43. Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines.
Balagon MF; Cellona RV; Cruz Ed; Burgos JA; Abalos RM; Walsh GP; Saunderson PR; Walsh DS
Am J Trop Med Hyg; 2009 Nov; 81(5):895-9. PubMed ID: 19861628
[TBL] [Abstract][Full Text] [Related]
44. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
Kaur I; Dogra S; Kumar B; Radotra BD
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
[TBL] [Abstract][Full Text] [Related]
45. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
[TBL] [Abstract][Full Text] [Related]
46. Newer drugs in leprosy.
Grosset JH
Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S14-8. PubMed ID: 11757174
[TBL] [Abstract][Full Text] [Related]
47. Lack of response to WHO/MDT; a case report.
Habtemariam H; Guebre-Xabier M
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):632-4. PubMed ID: 8151198
[No Abstract] [Full Text] [Related]
48. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
[TBL] [Abstract][Full Text] [Related]
49. Effectiveness of pefloxacin in the treatment of lepromatous leprosy.
N'Deli L; Guelpa-Lauras CC; Perani EG; Grosset JH
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):12-8. PubMed ID: 2181041
[TBL] [Abstract][Full Text] [Related]
50. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
51. Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi.
Boerrigter G; Pönnighaus JM; Fine PE; Wilson RJ
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):255-61. PubMed ID: 2071983
[TBL] [Abstract][Full Text] [Related]
52. Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
Fu X; Liu H; Zhang F
Am J Trop Med Hyg; 2015 Aug; 93(2):207-209. PubMed ID: 26251526
[No Abstract] [Full Text] [Related]
53. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
Dhople AM; Lamoureux LC; Gardner GD
Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
[TBL] [Abstract][Full Text] [Related]
55. Relapse of leprosy after multidrug therapy.
Dasananjali K
J Med Assoc Thai; 1996 Oct; 79(10):635-9. PubMed ID: 8996998
[TBL] [Abstract][Full Text] [Related]
56. Determination of in vivo and in vitro drug effects of mycobacteria from the mass spectrometric analysis of single organisms.
Haas M; Lindner B; Dietz M; Tebebe YB; Seydel U
Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):262-70. PubMed ID: 2071984
[TBL] [Abstract][Full Text] [Related]
57. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
Pattyn S; Grillone S
Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
[TBL] [Abstract][Full Text] [Related]
58. Recent trends in chemotherapy of leprosy.
Parikh DA; Maniar JK; Parikh AC; Ganapati R
J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
[No Abstract] [Full Text] [Related]
59. Silent iritis in treated bacillary negative leprosy.
Thompson K; Job CK
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
[TBL] [Abstract][Full Text] [Related]
60. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]